Cardiovascular disease applications represent upwards of €1bn ($1.1bn) of the ultrasound market. Royal Philips is number one globally in this segment, but Jeff Cohen, the company’s global general manager of ultrasound, insists that there is always work to do to ensure market supremacy is maintained.
Speaking to In Vivo during the company’s final preparations for the 2023 European Society of Cardiology (ESC) conference in Amsterdam,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?